Palatin Technologies, Inc. (PTNTD)
OTCMKTS · Delayed Price · Currency is USD
9.00
-0.20 (-2.20%)
At close: Sep 4, 2025
Palatin Technologies Revenue
Palatin Technologies had revenue of $350.00K in the twelve months ending March 31, 2025, down -94.07% year-over-year. In the fiscal year ending June 30, 2024, Palatin Technologies had annual revenue of $4.49M, down -7.49%.
Revenue (ttm)
350.00K
Revenue Growth
-94.07%
P/S Ratio
27.88
Revenue / Employee
11.67K
Employees
30
Market Cap
9.76M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 4.49M | -363.59K | -7.49% |
Jun 30, 2023 | 4.85M | 3.39M | 230.53% |
Jun 30, 2022 | 1.47M | 1.66M | -878.62% |
Jun 30, 2021 | -188.60K | -306.59K | -259.84% |
Jun 30, 2020 | 117.99K | -60.18M | -99.80% |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Federal National Mortgage Association | 28.89B |
Federal Home Loan Mortgage | 22.97B |
Alpine Auto Brokers | 129.78K |
Central Bancompany | 851.25M |
First National of Nebraska | 1.89B |
Jingbo Technology | 2.29M |
Mechanics Bank | 381.61M |
Procaps Group | 414.10M |
Palatin Technologies News
- 17 days ago - Boehringer Ingelheim and Palatin Technologies to develop potential first-in-class melanocortin receptor targeted treatment for patients with retinal diseases - GlobeNewsWire
- 27 days ago - Palatin Announces 1-for-50 Reverse Stock Split - PRNewsWire
- 7 weeks ago - Palatin Announces Positive Preclinical Efficacy Data for Oral MC4R Agonist PL7737 in Animal Model of Obesity - PRNewsWire
- 4 months ago - Palatin Technologies, Inc. (PTN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Palatin Reports Fiscal Year 2025 Third Quarter Results and Business Update - PRNewsWire
- 4 months ago - Palatin Presents Promising Preclinical Data on Melanocortin Agonists for Retinopathy at ARVO 2025 - PRNewsWire
- 4 months ago - Palatin Technologies Announces Closing of Reduced Public Offering - PRNewsWire
- 4 months ago - Palatin Technologies Announces Transition to OTC Pink Following NYSE American Delisting Notice - PRNewsWire